Drareg
Member
- Joined
- Feb 18, 2016
- Messages
- 4,772
Good article on how a lab in the uk is abusing the PCR test, not following the tests instructions or the WHO guidelines, not that the WHO are trustworthy but it’s worth noting.
It just so happened that this change in testing methods coincided with the arrival of a new variant around Christmas just in time to extend lockdowns, how much more evidence do the covid cult need of fraud on the part of politicians?
The UK Office for National Statistics (ONS) publish a regular infection survey that reports data on positive RT-PCR test results for SARS-COV-2 virus. This survey reports that a large proportion of positive test results are based on the detection of a single gene rather than on two or more genes as required in the manufacturer instructions for use, and by the WHO in their emergency use assessment. The proportion of positives called on single genes increased from mid-November to mid-December 2020, suggesting a shift in testing policy coincident with the reported significant increase in transmission of the new variant B1.1.7, and again starting January 2021. Without diagnostic validation of the single gene call, for both the original and the B1.1.7 variant it can only be assumed that, in the absence of confirmatory testing, many of the reported positive results may in fact be inconclusive, negative or from people who suffered past infection for SARS-COV-2.
If you have been following the coverage on this blog about Covid-19 false positives you will be interested to read that we have recently discovered that UK laboratories have been routinely recording a large proportion of Covid-19 test results as positive based on the presence of one target gene alone, when there should have been two or more, as required to comply with WHO rules and manufacturer instructions. For example, an average of 35% across the whole of the UK during week of 25 Jan 2021 were based on one gene only. Obviously, there is higher risk of encountering false positives when testing for single genes alone, because of the possibility of cross-reactivity with other HCOVs and prevalent nasopharyngeal bacteria or reagent contamination. Unless UK laboratories have performed diagnostic validation of their single gene call, for both the original and the B1.1.7 variant, and there is no evidence of this in the public domain, it can only be assumed that, in the absence of confirmatory testing, many of the reported positive results may in fact be inconclusive, negative or from people who suffered past infection for SARS-COV-2.
It just so happened that this change in testing methods coincided with the arrival of a new variant around Christmas just in time to extend lockdowns, how much more evidence do the covid cult need of fraud on the part of politicians?
The UK Office for National Statistics (ONS) publish a regular infection survey that reports data on positive RT-PCR test results for SARS-COV-2 virus. This survey reports that a large proportion of positive test results are based on the detection of a single gene rather than on two or more genes as required in the manufacturer instructions for use, and by the WHO in their emergency use assessment. The proportion of positives called on single genes increased from mid-November to mid-December 2020, suggesting a shift in testing policy coincident with the reported significant increase in transmission of the new variant B1.1.7, and again starting January 2021. Without diagnostic validation of the single gene call, for both the original and the B1.1.7 variant it can only be assumed that, in the absence of confirmatory testing, many of the reported positive results may in fact be inconclusive, negative or from people who suffered past infection for SARS-COV-2.
UK lighthouse laboratories testing for SARS-COV-2 may have breached WHO Emergency Use Assessment and potentially violated Manufacturer Instructions for Use
This is an updated version of a previous post. The main findings have been published today as a rapid response in the British Medical ...
probabilityandlaw.blogspot.com
If you have been following the coverage on this blog about Covid-19 false positives you will be interested to read that we have recently discovered that UK laboratories have been routinely recording a large proportion of Covid-19 test results as positive based on the presence of one target gene alone, when there should have been two or more, as required to comply with WHO rules and manufacturer instructions. For example, an average of 35% across the whole of the UK during week of 25 Jan 2021 were based on one gene only. Obviously, there is higher risk of encountering false positives when testing for single genes alone, because of the possibility of cross-reactivity with other HCOVs and prevalent nasopharyngeal bacteria or reagent contamination. Unless UK laboratories have performed diagnostic validation of their single gene call, for both the original and the B1.1.7 variant, and there is no evidence of this in the public domain, it can only be assumed that, in the absence of confirmatory testing, many of the reported positive results may in fact be inconclusive, negative or from people who suffered past infection for SARS-COV-2.